222 related articles for article (PubMed ID: 24940486)
1. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer.
Murase H; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
Mol Clin Oncol; 2014 Jul; 2(4):509-517. PubMed ID: 24940486
[TBL] [Abstract][Full Text] [Related]
2. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
[TBL] [Abstract][Full Text] [Related]
3. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the prognostic value and immune infiltration of
Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
Front Oncol; 2022; 12():936952. PubMed ID: 36147913
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer.
Gu ZY; Zhou R; Hong D; Han Y; Wang LZ; Li J; Zhang ZY; Shi CJ
Oral Dis; 2024 Apr; 30(3):1004-1017. PubMed ID: 36938639
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
7. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
8. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
Zhou Z; Wu B; Tang X; Ke R; Zou Q
Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system.
La Rosa S; Uccella S; Erba S; Capella C; Sessa F
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):319-28. PubMed ID: 11759058
[TBL] [Abstract][Full Text] [Related]
12. Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis.
Kim HS; Kim JH; Jang HJ; Han B; Zang DY
J Cancer; 2019; 10(1):20-27. PubMed ID: 30662521
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
14. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
15. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.
Quintanal-Villalonga Á; Ferrer I; Guruceaga E; Cirauqui C; Marrugal Á; Ojeda L; García S; Zugazagoitia J; Muñoz-Galván S; Lopez-Rios F; Montuenga L; Vicent S; Molina-Pinelo S; Carnero A; Paz-Ares L
EBioMedicine; 2020 Mar; 53():102683. PubMed ID: 32114392
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.
Heublein S; Pfisterer J; du Bois A; Anglesio M; Aminossadati B; Bhatti I; Sehouli J; Wimberger P; Schochter F; Hilpert F; Hillemanns P; Kalder M; Schroeder W; Mahner S; Burges A; Canzler U; Gropp-Meier M; Jackisch C; Harter P; Kommoss S; Marmé F
Lab Invest; 2024 Apr; 104(4):100321. PubMed ID: 38154497
[TBL] [Abstract][Full Text] [Related]
17. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Erber R; Rübner M; Davenport S; Hauke S; Beckmann MW; Hartmann A; Häberle L; Gass P; Press MF; Fasching PA
Breast Cancer Res Treat; 2020 Nov; 184(2):311-324. PubMed ID: 32852708
[TBL] [Abstract][Full Text] [Related]
18. Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations.
Fu W; Chen L; Wang Z; Kang Y; Wu C; Xia Q; Liu Z; Zhou J; Liang G; Cai Y
Phys Chem Chem Phys; 2017 Feb; 19(5):3649-3659. PubMed ID: 28094372
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma.
Tsimafeyeu I; Demidov L; Stepanova E; Wynn N; Ta H
Scand J Urol Nephrol; 2011 Apr; 45(3):190-5. PubMed ID: 21329481
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Ipenburg NA; Koole K; Liem KS; van Kempen PM; Koole R; van Diest PJ; van Es RJ; Willems SM
Target Oncol; 2016 Feb; 11(1):17-27. PubMed ID: 26115874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]